Viveve Medical (VIVE) Tops Q3 EPS by 7c

Viveve Medical (NASDAQ: VIVE) reported Q3 EPS of ($0.59), $0.07 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $17 million versus the consensus estimate of $1.68 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion